Apollo Endosurgery
Edit

Apollo Endosurgery

http://apolloendo.com/
Last activity: 17.04.2023
Categories: BrandCareHardwareHealthTechInformationLearnMedTechProductSkinTechnology
Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, X-Tack TM Endoscopic HeliX Tacking System and the ORBERA® Intragastric Balloon.
Followers
1.53K
Followers
10.22K
Mentions
33
Location: United States, Texas, Austin
Employees: 201-500
Total raised: $50M
Founded date: 2006

Investors 5

Funding Rounds 1

DateSeriesAmountInvestors
18.12.2013-$50M-

Mentions in press and media 33

DateTitleDescriptionSource
17.04.2023L’obésité : la pandémie silencieuse du 21ème siècleInfographie - obésité La solution efficace pour les patients adultes pourrait être la multidisciplin...einpresswi...
12.04.2023Globesity: the silent pandemic of the 21st centuryObesity in the UK infographic Multidisciplinary and new incisionless endoscopic technique may be an ...einpresswi...
07.11.2022Apollo Endosurgery to Participate in Upcoming Investor Confe...AUSTIN, TX / ACCESSWIRE / November 7, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:A...accesswire...
01.11.2022Apollo Endosurgery, Inc. Reports Record $19.6 million Global...Grew global revenue 20% GAAP, 24% in constant currency Received FDA authorization for Apollo ESGTM a...accesswire...
02.08.2022Apollo Endosurgery, Inc. Reports Record Global Revenue in Se...Grew global revenue 16% (20% in constant currency) as adoption increased across all product lines Se...accesswire...
29.07.2022Apollo Endosurgery Announces Publication in the Lancet of La...Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™ AUSTIN, TX / ACCESSWIRE /...accesswire...
31.05.2022Digestive Disease Week 2022 Adds to the Growing Wave of Clin...AUSTIN, TX / ACCESSWIRE / May 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN)...accesswire...
18.05.2022Apollo Endosurgery Products to Take Center Stage at Digestiv...AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN)...accesswire...
04.04.2022Apollo Endosurgery Appoints Jeannette Bankes to Board of Dir...Veteran Brings 30 Years of Multinational Healthcare Leadership Experience AUSTIN, TX / ACCESSWIRE / ...accesswire...
18.01.2022Apollo Endosurgery : Appoints Keely Scamperle as Vice Presid...Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access Jan...marketscre...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In